Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by lscfaon Apr 18, 2024 7:52pm
105 Views
Post# 35997071

RE:RE:RE:No clue

RE:RE:RE:No clue

Eli Lily's Zepbound does not cure sleep apnea. It reduces sleep apnea thus the need to also use PAP therapy.    

- - - - - - - - - - - - - - - -

At a year, those with moderate-to-severe obstructive sleep apnea who were taking the medication and not using PAP therapy saw a reduction of 27.4 events per hour, compared with a reduction of 4.8 events per hour in the participants who got the placebo.

In the second study, researchers found that people who used or planned to use PAP therapy and took the drug saw a slightly larger reduction in the number of events they had while they were sleeping. At 52 weeks, those who took the drug saw an average reduction of 30.4 events per hour compared with an average reduction of six events per hour in people who got a placebo. In the second study, people on the drug saw a weight reduction of 20.1% from their baseline compared with 2.3% among those taking the placebo

<< Previous
Bullboard Posts
Next >>